HIV treatment has no benefit for hospitalised Covid-19 patients

Must read

How to disable and delete Samsung Pay from your Galaxy phone

When it comes to paying conveniently, Samsung Pay makes using your phone as a bank card an easy process; however, there may come...

Should I buy an SSD for my PS4 or PS4 Pro?

Wondering whether you should buy an SSD for your PS4 or PS4 Pro? Then you've landed on the right page. Solid-state storage is...

You Really Are Better Off Spending Your Money On An HP Omen 15 Gaming Laptop

As we resume the Intel vs AMD battles in earnest again, after many years, the Dell G5 15 SE gaming laptop sits very...

Games of the Generation: Stardew Valley is a welcome break from the chaos of the world

Games of the GenerationAs we approach the launch of the PS5 and Xbox Series X, TechRadar is looking back at the games that...
Bhawani Singhhttps://techmepro.com
I am a blogger who believes in delivering latest tech news from around the world to my viewers.

A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.

British scientists running the RECOVERY trial at the University of Oxford in June said interim results had convincingly ruled out any meaningful benefit of lopinavir-ritonavir in lowering mortality among hospitalised patients.


Publishing the full findings of the study in The Lancet medical journal, the scientists said that 23% of those given the drugs died within 28 days of treatment beginning, compared to 22% of those given usual care.

The treatment also did not reduce the length of a patient’s hospital stay or the chances they would be put on a ventilator.

“Results from this trial show that it is not an effective treatment for patients admitted to hospital with COVID–19,” said Professor Martin Landray from the Nuffield Department of Population Health at the University of Oxford, who co-leads the RECOVERY trial.


AbbVie Inc’s Kaletra is a combination of the drugs lopinavir and ritonavir, used together to fight HIV. The company had increased its supplies while it was determining whether it can be used to treat COVID-19.

The World Health Organization (WHO) in July discontinued its trial of lopinavir-ritonavir after it failed to reduce mortality.

The lopinavir-ritonavir arm of the RECOVERY trial involved 1,616 patients receiving the drugs, and 3,424 receiving usual care alone.

The Oxford-based RECOVERY trial has been examining the effectiveness of a range of possible COVID-19 treatments, enrolling 13,000 patients in all.

The arm of the trial studying dexamethasone, a steroid, found it reduced the death rate of patients that required oxygen. Another arm found the malaria drug hydroxychloroquine, touted by U.S. President Donald Trump, had no benefit as a treatment.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Source link

More articles

Leave a Reply

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisement -

Latest article

OnePlus launches IDEAS 2.0 to help improve OxygenOS

Having one of the most active online communities has seen OnePlus become a major player in the Android space over the past few...

India’s most beautiful, most respected, most versatile celebrities in pics

Deepika Padukone is also India’s Most Glamorous with a top score 60.3. In Bollywood, Priyanka Chopra and Ranbir Kapoor are seen to have...

Fears over 'weakening' of UK green watchdog

Campaigners fear that a body designed to protect the environment is being undermined. Source link

TikTok shrugs off Trump attack with expansion plans

Anti-Trump TikTokkers not declaring paid content Source link

What is T-Mobile TVision, and How Much Does it Cost?

T-MobileIt seems like every technology company has its own streaming service these days. T-Mobile is a recent entrant in the field with its “TVision” live...
- Advertisement -